Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
We performed a clinical study of pneumococcal endocarditis (PE) in adults at 15 major Spanish hospitals during a 21-year period (1978-1998). During this time, 63 patients had PE due to Streptococcus pneumoniae diagnosed. Of the 63 isolates recovered from these patients, 24 (38%) and 6 (10%) showed resistance to penicillin (minimum inhibitory concentration [MIC], 0.1-4 microg/mL) and cefotaxime (MIC, 1 microg/mL), respectively. Twenty-two (35%) of the patients died. Left-side heart failure, but not penicillin resistance, was independently associated with a higher risk of death (odds ratio, 1.33; 95% confidence interval, 1.04-1.71; P=.026). Patients without meningitis who had PE due to penicillin-resistant S. pneumoniae could be treated with high-dose penicillin or a third-generation cephalosporin if the MIC for penicillin was < or =1 microg/mL. For patients with concurrent meningitis, high doses of cefotaxime could be used if the MIC for cefotaxime was < or =1 microg/mL. Early recognition of heart failure and surgery may help to decrease mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Case-Control Studies: Design, Conduct, Analysis.
Youkeles, L., & Schlesselman, J. J. (1983) · Journal of the American Statistical Association · doi:10.2307/2288156 · Cited by 2,346
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Infective Endocarditis: An Analysis Based on Strict Case Definitions
VON REYN, C. F., LEVY, B. S., ARBEIT, R. D., FRIEDLAND, G., & CRUMPACKER, C. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-505 · Cited by 775
Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330802 · Cited by 773
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610 · cited 1×
“Recent recommendations indicate that all pneumococcal isolates that are not related to cases of meningitis and for which the MIC of penicillin is 1 mg/mL should be considered susceptible and that those with an MIC of 2 mg/mL or 4 mg/mL should be considered intermediately susceptible or resistant, respectively [39, 40].”
BackgroundManagement of Infections Caused by Antibiotic-Resistant Streptococcus Pneumoniae
Wood, A. J. J., Friedland, I. R., & McCracken, G. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310607 · Cited by 578
Wilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · cited 1×
“pneumoniae in adults [3, 13, 14], and the optimal therapy for this entity remains unknown [10, 15, 16].”
BackgroundTreatment of Bacterial Meningitis
Quagliarello, V. J., & Scheld, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361007 · Cited by 491
INFECTIVE ENDOCARDITIS: A REVIEW OF 125 CASES FROM THE UNIVERSITY OF WASHINGTON HOSPITALS, 1963–72
PELLETIER, L. L., & PETERSDORF, R. G. (1977) · Medicine · doi:10.1097/00005792-197707000-00002 · Cited by 453
Pallares, R., Gudiol, F., Liñares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170104 · Cited by 373 · cited 1×
“teremic pneumonia [6] but not in patients with men-”
BackgroundInvasive Pneumococcal Infections: Incidence, Predisposing Factors, and Prognosis
Burman, L. A., Norrby, R., & Trollfors, B. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.2.133 · Cited by 324
Wilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 288
Fenoll, A., Bourgon, C. M., Munoz, R., Vicioso, D., & Casal, J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.56 · Cited by 284
Metlay, J. P., Hofmann, J., Cetron, M. S., Fine, M. J., Farley, M. M., Whitney, C., & Breiman, R. F. (2000) · Clinical Infectious Diseases · doi:10.1086/313716 · Cited by 270 · cited 1×
“monia [8] but not of pneumococcal meningitis [9].”
BackgroundLinares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F., Viladrich, P. F., & Martin, R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.1.99 · Cited by 248
Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae
Kaplan, S. L., & Mason, E. O. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.628 · Cited by 232 · cited 2×
“Some authorities now recommend (1) empiric treatment of all cases of pneumococcal meningitis with either ceftriaxone or cefotaxime plus vancomycin or rifampin until susceptibility is known, and (2) maintenance of the latter regimen if isolates show cefotaxime MICs of 1 mg/mL [12, 42, 43].”
BackgroundDrug‐Resistant Streptococcus pneumoniae
Campbell, Jr., & Silberman, R. (1998) · Clinical Infectious Diseases · doi:10.1086/520286 · Cited by 191
Review of Pneumococcal Endocarditis in Adults in the Penicillin Era
Aronin, S. I., Mukherjee, S. K., West, J. C., & Cooney, E. L. (1998) · Clinical Infectious Diseases · doi:10.1086/516279 · Cited by 170 · cited 1×
“00 cause of bacterial endocarditis [2, 3], although the true”
BackgroundDecreased susceptibility of penicillin-resistant pnenmococci to twenty-four βlactam antibiotics
Liñares, J., Alonso, T., Pérez, J. L., Ayats, J., Dominguez, M. A., Pallarés, R., & Martin, R. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.3.279 · Cited by 161
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
Viladrich, P. F., Gudiol, F., Liñares, J., Rufi, G., Ariza, J., & Pallarés, R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90061-7 · Cited by 155
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae
Paris, M. M., Ramilo, O., & McCracken, G. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2171 · Cited by 128 · cited 1×
“Some authorities now recommend (1) empiric treatment of all cases of pneumococcal meningitis with either ceftriaxone or cefotaxime plus vancomycin or rifampin until susceptibility is known, and (2) maintenance of the latter regimen if isolates show cefotaxime MICs of 1 mg/mL [12, 42, 43].”
BackgroundGarcía-Leoni, M. E., Cercenado, E., Rodeño, P., de Quirós, J. C. L. B., Hernández, D. M., & Bouza, E. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.427 · Cited by 111
Identification of high-risk subgroups in infective endocarditis and the role of echocardiography
ERBEL, R., LIU, F., GE, J., ROHMANN, S., & KUPFERWASSER, I. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060961 · Cited by 103 · cited 1×
“side heart failure has also been associated with increased mortality in association with infective endocarditis in general [36, 37].”
BackgroundLefort, A., Mainardi, J.-L., Selton-Suty, C., Casassus, P., Guillevin, L., & Lortholary, O. (2000) · Medicine · doi:10.1097/00005792-200009000-00006 · Cited by 102 · cited 2×
“00 cause of bacterial endocarditis [2, 3], although the true”
BackgroundFiore, A. E., Moroney, J. F., Farley, M. M., Harrison, L. H., Patterson, J. E., Jorgensen, J. H., Cetron, M., Kolczak, M. S., Breiman, R. F., & Schuchat, A. (2000) · Clinical Infectious Diseases · doi:10.1086/313606 · Cited by 89 · cited 1×
“monia [8] but not of pneumococcal meningitis [9].”
BackgroundViladrich, P. F., Cabellos, C., Pallarés, R., Tubau, F., Martínez-Lacasa, J., Liñares, J., & Gudiol, F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.218 · Cited by 88 · cited 1×
“These results agree with those of a small study in which 7 episodes of pneumococcal meningitis caused by isolates with decreased susceptibility to cefotaxime (MICs of 1 mg/mL for 5 episodes and 2 mg/mL for 2 episodes) were successfully treated with high doses of cefotaxime [41].”
ResultBohr, V. A., Rasmussen, N., Hansen, B., Gade, A., Kjersem, H., Johnsen, N. J., & Paulson, O. B. (1985) · Journal of Infection · doi:10.1016/s0163-4453(85)91585-3 · Cited by 73
A Fresh Look at the Definition of Susceptibility of Streptococcus pneumoniae to β-Lactam Antibiotics
Musher, D. M., Bartlett, J. G., & Doern, G. V. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.21.2538 · Cited by 63 · cited 1×
“Recent recommendations indicate that all pneumococcal isolates that are not related to cases of meningitis and for which the MIC of penicillin is 1 mg/mL should be considered susceptible and that those with an MIC of 2 mg/mL or 4 mg/mL should be considered intermediately susceptible or resistant, respectively [39, 40].”
Background(1993) · PubMed · Cited by 50
Austrian Syndrome Caused by Highly Penicillin-Resistant Streptococcus pneumoniae
Munoz, P., Sainz, J. J. G., Rodríguez‐Créixems, M., Santos, J., Alcalá, L., & Bouza, E. (1999) · Clinical Infectious Diseases · doi:10.1086/313542 · Cited by 37 · cited 1×
“pneumoniae in adults [3, 13, 14], and the optimal therapy for this entity remains unknown [10, 15, 16].”
BackgroundWilson, W. R. (1998) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1998.tb00863.x · Cited by 31
Goldman, M. E., Fisher, E. A. A., Winters, S. C., Reichstein, R., Staville, K., Gorlin, R., & Fuster, V. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02494-8 · Cited by 19 · cited 1×
“side heart failure has also been associated with increased mortality in association with infective endocarditis in general [36, 37].”
BackgroundWhitby, S., Pallera, A., Schaberg, D. R., & Bronze, M. S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1176 · Cited by 19 · cited 1×
“pneumoniae in adults [3, 13, 14], and the optimal therapy for this entity remains unknown [10, 15, 16].”
BackgroundTreatment of experimental endocarditis due to penicillin-resistant Streptococcus pneumoniae
Guerrero, M. L. F., Arbol, F., Verdejo, C., Roblas, R. F., & Soriano, F. G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1103 · Cited by 18 · cited 1×
“This approach has also been used successfully in patients with penicillin-resistant pneumococcal bacteremic pneumonia [11] and in an experimental model of PE due to penicillin-resistant organisms [38].”
[Endocarditis caused by Streptococcus pneumoniae. Report of 3 new cases].
Montejo, M., Aguirrebengoa, K., Iruretagoyena, J. R., Irastorza, G. R., de Maeztu, J. C. I., Agosti, J., Jl, H., & Gochi, R. (1995) · PubMed · Cited by 2
Self-citation[Pneumococcal endocarditis: apropos of 3 cases].
Dronda, F., Jiménez, M. C., de Mora, P. M., Pérez-Hernández, F., Pérez-Elías, M. J., Moreno, S., Sanz, J., & Martínez, F. (1989) · PubMed · Cited by 1
Self-citation
Research works printed but not linked: 8
- Dronda F, 1989, Enferm Infecc Microbiol Clin, 7, 321
- Sanchez Porto A, 1991, Med Clin (Barc), 96, 114
- Aguado JM, 1993, Med Clin (Barc), 100, 325
- Nunez A, 1994, Med Clin (Barc), 102, 74
- Montejo M, 1995, Enferm Infecc Microbiol Clin, 13, 573
- Washington JA II, 1980, DC: American Society for Microbiology, 453
- Linares J, 1979, Spain, 90, 1992
- Hoen B, 1993, Eur J Med, 2, 28
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Self-citation2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Metadata
- Authors
- Martínez, E., Miró, J. M., Almirante, B., Aguado, J. M., Fernandez‐Viladrich, P., Fernandez‐Guerrero, M. L., Villanueva, J. L., Dronda, F., Moreno‐Torrico, A., Montejo, M., Llinares, P., Gatell, J. M., & Spanish Pneumococcal Endocarditis Study Group
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Reina Sofía (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Hospital de Cruces (ES)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-15
- Volume
- 35
- Issue
- 2
- Pages
- 130-139
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2052693941
- Cited by
- 79
- References
- 41
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 5 · 2021: 1 · 2019: 7 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- pneumococcal endocarditis, Streptococcus pneumoniae, penicillin resistance, cefotaxime resistance, antimicrobial susceptibility, mortality, left heart failure, meningitis, high-dose penicillin, third-generation cephalosporins, prognosis
- MeSH terms
- Adult, Aged, Cefotaxime, Cephalosporins, Dose-Response Relationship, Drug, Drug Administration Schedule, Endocarditis, Bacterial, Female, Heart Failure, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Penicillin Resistance, Penicillins, Pneumococcal Infections, Prognosis, Prospective Studies, Spain, Streptococcus pneumoniae, Treatment Outcome, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.